Founder of Fit Body Boot Camp Launches Breakthrough Glute Workout Device

Glute Workout Device:

Steve Hochman, renowned southern California trainer and co-founder of Fit Body Boot Camp, has invented the first wearable glute-activating device, now available through crowdfunding on Indiegogo. Check it out here!

“After training thousands of clients over the past 20 years, I discovered that 90 percent of people struggle to activate their glutes,” said Hochman. “The GX5 TRAINER’s patent-pending design redirects your body’s energy allowing your glutes to work up to 87% more.”
The set straps to your shoe for maximum glute activation, form correction, and pain alleviation during all lower body workouts. The GX5 TRAINER™ is the only wearable product on the market that corrects your form during both stationary and moving exercises, such as walking lunges.

By purchasing the GX5 TRAINER™, you will also receive free access to the GX5 FIT app featuring:

6 Week Booty Lift Series
How-to library for popular glute exercises
Live and recorded GX5 glute classes

“We believe this product has the potential to take off on a global scale,” said Hochman. “The GX5 TRAINER™ is ready for mass-production, but we need more capital to really make a splash in the U.S. health and fitness market. We’ve decided to launch the product with Indiegogo, a platform to fund ingenious, work-in-progress products and ideas. We’re ready for mass production and we will begin shipping in June!”

SourceGX5 FIT

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution